Results 91 to 100 of about 2,611 (175)

Anti-TIF-1γ dermatomyositis: Erythematous eruption with weakness and normal creatine kinase. [PDF]

Skin Health Dis
Mackie L, Wijesuriya N, Iyer A.
europepmc   +1 more source

Quality of Care of Adult Patients With Allergic Diseases in Urban, Rural, and Remote Primary Care Sites in the Philippines. [PDF]

J Prim Care Community Health
Tan-Lim CSC, Falcon RMG, Feliciano JF, Fong MB, Javelosa MAU, Dans LF, Isip-Tan ITC, Sanchez JT, Rey MP, Dans AML.   +9 more
europepmc   +1 more source

Morgellons-like Disease of the Scalp.

Int J Trichology
Fiorese G, Uribe NC, Trüeb RM.
europepmc   +1 more source

Attenuation of senile pruritus by PAC-14028-mediated downregulation of the NF-κB and MAPK pathways. [PDF]

Int J Immunopathol Pharmacol
Yoon JH, Woo BY, Kim MY, Cho JY.
europepmc   +1 more source

Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss. [PDF]

Intern Med
Kida Y, Itoh S, Yoshimi S, Kobayashi Y, Izumi M.   +4 more
europepmc   +1 more source

Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Study. [PDF]

Acta Derm Venereol
Renkhold L, Pereira MP, Pereira MP, Loser K, Metze D, Baeumer D, Melzer N, Reinhardt M, Tsianakas A, Luger T, Mess C, Becker R, Hambüchen C, Agelopoulos K, Ständer S.   +14 more
europepmc   +1 more source

The synthetic cannabinoid agonist WIN 55,212-2 reduces experimental pruritus via CB₂ receptor activation. [PDF]

Neuropharmacology
Reck AM, Siderovski DP, Kinsey SG.
europepmc   +1 more source

Drug-associated tongue discoloration: a comprehensive assessment of USFDA adverse event reporting system using disproportionality analysis. [PDF]

BDJ Open
Sridharan K, Sivaramakrishnan G.
europepmc   +1 more source

Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2.

Am J Nephrol
Fishbane S, Clegg DJ, Lerma EV, Rastogi A, Budden J, Morin I, Wen W, Menzaghi F, Topf J.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immunomodulating Agents as Antipruritics

Dermatologic Clinics, 2018
Chronic pruritus, or itch lasting greater than 6 weeks, is an increasingly common and debilitating medical problem. Recent studies have unveiled previously unrecognized neuroimmune axes whereby inflammatory cytokines act directly on the nervous system to promote itch.
Ilana Rosman, Brian Kim, Zachary Nahmias   +2 more
exaly   +4 more sources